A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 (LOTUS)

被引：0
|
作者：
Pouchain, Denis [1 ]
Boussageon, Remy [1 ,2 ,3 ]
Leroux, Gerard [4 ]
机构：
[1] CNGE, Conseil Sci, Paris, France
[2] Univ Claude Bernard Lyon 1, Coll Univ Med Gen, Lyon, France
[3] Fac RTH Laennec, Lab Biometrie & Biol Evolut, UMR 5558, Lyon, France
[4] Univ Paris Est Creteil, Dept Med Gen, Paris, France
来源：
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE | 2020年 / 162期
关键词：
IN-VITRO; SARS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：172 / 173
页数：2
相关论文
共 50 条
  • [31] Acute Respiratory Distress Syndrome due to COVID-19 in India and efficacy of Indian Siddha drugs - A Trial of lopinavir-Ritonavir
    Rajeshbabu, P.
    Priadharsini, K.
    Riyaz, S. U. Mohammed
    Dhayalan, Manikandan
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2022, 16 (02): : 763 - 768
  • [32] High rate of major drug-drug interactions of lopinavir-ritonavir for COVID-19 treatment
    Macias, Juan
    Pinilla, Ana
    Lao-Dominguez, Francisco A.
    Corma, Anais
    Contreras-Macias, Enrique
    Gonzalez-Serna, Alejandro
    Gutierrez-Pizarraya, Antonio
    Fernandez-Fuertes, Marta
    Morillo-Verdugo, Ramon
    Trigo, Marta
    Real, Luis M.
    Pineda, Juan A.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [33] In COVID-19, adding lopinavir-ritonavir to usual care did not shorten time to clinical improvement
    Yang, Philip
    Tekwani, Seema
    Martin, Greg S.
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (12) : JC63 - JC63
  • [34] Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir
    Yin, Guosheng
    Zhang, Chenyang
    Jin, Huaqing
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2020, 6 (03): : 231 - 241
  • [35] Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)
    Schoergenhofer, Christian
    Jilma, Bernd
    Stimpfl, Thomas
    Karolyi, Mario
    Zoufaly, Alexander
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (08) : 670 - +
  • [36] A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19
    Maciorowski, Dawid
    Idrissi, Samir Z. El
    Gupta, Yash
    Medernach, Brian J.
    Burns, Michael B.
    Becker, Daniel P.
    Durvasula, Ravi
    Kempaiah, Prakasha
    SLAS DISCOVERY, 2020, 25 (10) : 1108 - 1122
  • [37] Lopinavir-Ritonavir Associated Acute Kidney Injury Is Not Related to Crystalluria in Critically Ill COVID-19 Patients
    Arrestier, Romain
    Stehle, Thomas
    Letavernier, Emmanuel
    Mekontso-Dessap, Armand
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (11): : 2119 - 2119
  • [38] Is the efficacy of remdesivir so different from that of lopinavir-ritonavir in severe COVID-19? The answer by real time-PCR: a narrative review
    Duarte, Tiago Isidoro
    Vieira, Cesar
    Pimentel, Carlos
    Cascao, Mariana
    Torre, Marta
    Santos-Lima, Joaquim
    Sequeira, Tania
    Germano, Nuno
    Corte-Real, Rita
    Bento, Luis
    ANAESTHESIOLOGY INTENSIVE THERAPY, 2021, 53 (04) : 363 - 365
  • [39] An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19
    Ader, Florence
    Peiffer-Smadja, Nathan
    Poissy, Julien
    Bouscambert-Duchamp, Maude
    Belhadi, Drifa
    Diallo, Alpha
    Delmas, Christelle
    Saillard, Juliette
    Dechanet, Aline
    Mercier, Noemie
    Dupont, Axelle
    Alfaiate, Toni
    Lescure, Francois-Xavier
    Raffi, Francois
    Goehringer, Francois
    Kimmoun, Antoine
    Jaureguiberry, Stephane
    Reignier, Jean
    Nseir, Saad
    Danion, Francois
    Clere-Jehl, Raphael
    Bouiller, Evin
    Navellou, Jean-Christophe
    Tolsma, Violaine
    Cabie, Andre
    Dubost, Clement
    Courjon, Johan
    Leroy, Sylvie
    Mootien, Joy
    Gaci, Rostane
    Mourvillier, Bruno
    Faure, Emmanuel
    Pourcher, Valerie
    Gallien, Sebastien
    Launay, Odile
    Lacombe, Karine
    Lanoix, Jean-Philippe
    Makinson, Alain
    Martin-Blondel, Guillaume
    Bouadma, Lila
    Botelho-Nevers, Elisabeth
    Gagneux-Brunon, Amandine
    Epaulard, Olivier
    Piroth, Lionel
    Wallet, Florent
    Richard, Jean-Christophe
    Reuter, Jean
    Staub, Therese
    Lina, Bruno
    Noret, Marion
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) : 1826 - 1837
  • [40] Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI): A multicenter observational study
    Elmekaty, Eman Zeyad, I
    Alibrahim, Rim
    Hassanin, Rania
    Eltaib, Sitelbanat
    Elsayed, Ahmed
    Rustom, Fatima
    Ibrahim, Mohamed Izham Mohamed
    Abu Khattab, Mohammed
    Al Soub, Hussam
    Al Maslamani, Muna
    Al-Khal, Abdullatif
    PLOS ONE, 2022, 17 (05):
12345